These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 27393273)

  • 1. [Not Available].
    Chaabane A; Aouam K; Fredj NB; Boughattas NA
    Therapie; 2010; 65(6):543-50. PubMed ID: 27393273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DRESS syndrome: 11 case reports and a literature review].
    Chaabane A; Aouam K; Ben Fredj N; A Boughattas N
    Therapie; 2010; 65(6):543-50. PubMed ID: 21176761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients.
    Cabañas R; Calderon O; Ramirez E; Fiandor A; Prior N; Caballero T; Herránz P; Bobolea I; López-Serrano MC; Quirce S; Bellón T
    J Investig Allergol Clin Immunol; 2014; 24(6):425-30. PubMed ID: 25668894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS).
    Santiago F; Gonçalo M; Vieira R; Coelho S; Figueiredo A
    Contact Dermatitis; 2010 Jan; 62(1):47-53. PubMed ID: 20136879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
    Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
    Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl.
    Buyuktiryaki AB; Bezirganoglu H; Sahiner UM; Yavuz ST; Tuncer A; Kara A; Sackesen C
    Australas J Dermatol; 2012 Nov; 53(4):274-7. PubMed ID: 22524313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DRESS syndrome: a literature review.
    Cacoub P; Musette P; Descamps V; Meyer O; Speirs C; Finzi L; Roujeau JC
    Am J Med; 2011 Jul; 124(7):588-97. PubMed ID: 21592453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL; Pillow MT
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
    Ortonne N; Valeyrie-Allanore L; Bastuji-Garin S; Wechsler J; de Feraudy S; Duong TA; Delfau-Larue MH; Chosidow O; Wolkenstein P; Roujeau JC
    Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRESS Syndrome: Drug Rash with Eosinophilia and Systemic Symptoms.
    Thacker H; Shah M; Tulle R
    J Assoc Physicians India; 2015 May; 63(5):78-9. PubMed ID: 26591154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DRESS syndrome: the great clinical mimicker.
    Fleming P; Marik PE
    Pharmacotherapy; 2011 Mar; 31(3):332. PubMed ID: 21361742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised.
    Nam YH; Park MR; Nam HJ; Lee SK; Kim KH; Roh MS; Um SJ; Son CH
    Allergol Immunopathol (Madr); 2015; 43(1):19-24. PubMed ID: 24388810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms).
    Boccara O; Valeyrie-Allanore L; Crickx B; Descamps V
    Eur J Dermatol; 2006; 16(6):666-8. PubMed ID: 17229608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug reaction with eosinophilia and systemic symptoms (DRESS)].
    Descamps V
    Rev Prat; 2012 Dec; 62(10):1347-52. PubMed ID: 23424909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).
    Fields KS; Petersen MJ; Chiao E; Tristani-Firouzi P
    J Drugs Dermatol; 2005; 4(4):510-3. PubMed ID: 16004028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
    Tas S; Simonart T
    Acta Clin Belg; 1999 Aug; 54(4):197-200. PubMed ID: 10544509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
    Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J;
    Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
    Roquin G; Peres M; Lerolle N; Dib N; Mercat A; Croue A; Augusto JF
    Ann Pharmacother; 2010 Dec; 44(12):1998-2000. PubMed ID: 21098750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of drug-induced reactions in DRESS patients.
    Picard D; Vellar M; Janela B; Roussel A; Joly P; Musette P
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):801-4. PubMed ID: 24628777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug neosensitization during anticonvulsant hypersensitivity syndrome.
    Gaig P; García-Ortega P; Baltasar M; Bartra J
    J Investig Allergol Clin Immunol; 2006; 16(5):321-6. PubMed ID: 17039674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.